These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3746580)

  • 1. Sterile ophthalmic ointment and suspension manufacturing.
    Abshire R; Cash P
    J Parenter Sci Technol; 1986; 40(3):97-9. PubMed ID: 3746580
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comments and control studies on the size of drug particles contained in ophthalmic ointments].
    Doden W; Faulborn J
    Klin Monbl Augenheilkd; 1967; 150(5):727-32. PubMed ID: 5586134
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prescription moderated preparation of bacteria non-contaminated eyedrop solutions and eye ointment 1].
    Frauch P
    Pharm Acta Helv; 1970 Jan; 45(1):1-17. PubMed ID: 4908302
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prescription controlled preparation of noncontaminated with microbes eyedrops and eye ointments].
    Frauch P
    Pharm Acta Helv; 1970 Feb; 45(2):75-88. PubMed ID: 5436325
    [No Abstract]   [Full Text] [Related]  

  • 5. [Prescription preparation of microbially uncontaminated eyedrops eye ointments. 3].
    Frauch P
    Pharm Acta Helv; 1970 Jun; 45(6):329-44. PubMed ID: 5426097
    [No Abstract]   [Full Text] [Related]  

  • 6. Basics of Sterile Compounding: Ophthalmic Preparations, Part 2: Suspensions and Ointments.
    Allen LV
    Int J Pharm Compd; 2016; 20(6):495-500. PubMed ID: 28339389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guidelines for the preparation of sterile ophthalmic products.
    Reynolds LA
    Am J Hosp Pharm; 1991 Nov; 48(11):2438-9. PubMed ID: 1746580
    [No Abstract]   [Full Text] [Related]  

  • 8. [Extempore prepared ophthalmic solutions and ophthalmic ointments].
    Berggren L; Renström A
    Lakartidningen; 1978 Jan; 75(3):137-40. PubMed ID: 625158
    [No Abstract]   [Full Text] [Related]  

  • 9. [Study on the quality and stability of mass-produced and prepared for storage ointments. V. Quality of mass-produced suspension-ointments and emulsion-suspension ointments].
    Sarsúnová M; Gremenová B; Schusterová S
    Cesk Farm; 1974 May; 23(4):139-43. PubMed ID: 4830773
    [No Abstract]   [Full Text] [Related]  

  • 10. Procedures important in the manufacture of ophthalmic preparations.
    Rosenberg SJ
    Bull Parenter Drug Assoc; 1970; 24(2):94-7. PubMed ID: 5439918
    [No Abstract]   [Full Text] [Related]  

  • 11. [Particle size determination in suspension and emulsion ointments. The modern status of pharmacopoeia requirements].
    Stejskalová E; Safarík L
    Cesk Farm; 1981 Feb; 30(1):21-5. PubMed ID: 7237584
    [No Abstract]   [Full Text] [Related]  

  • 12. Ophthalmic preservatives and vehicles.
    Mullen W; Shepherd W; Labovitz J
    Surv Ophthalmol; 1973; 17(6):469-83. PubMed ID: 4213278
    [No Abstract]   [Full Text] [Related]  

  • 13. [Complex evaluation of drugs prepared on prescription in an ophtalmology department].
    Sarsúnová M; Kahay J; Kadlecová O; Salava M
    Cesk Farm; 1968 Feb; 17(2):58-67. PubMed ID: 5663008
    [No Abstract]   [Full Text] [Related]  

  • 14. Eye drops for rural populations.
    Taylor J
    World Health Forum; 1993; 14(1):63-6. PubMed ID: 8439380
    [No Abstract]   [Full Text] [Related]  

  • 15. Sterile ophthalmic ointments--pilot plant phase.
    O'Neill JL; Polli GP; Fong DT
    Bull Parenter Drug Assoc; 1973; 27(5):201-6. PubMed ID: 4746694
    [No Abstract]   [Full Text] [Related]  

  • 16. [The sterility of non-injectable pharmaceutical products].
    Sekules G; Maragliano E
    Boll Chim Farm; 1969 May; 108(5):273-91. PubMed ID: 5806821
    [No Abstract]   [Full Text] [Related]  

  • 17. New process for the manufacture of sterile ophthalmic ointments.
    Smith GG; Fonner DE; Griffin JC
    Bull Parenter Drug Assoc; 1975; 29(1):18-25. PubMed ID: 1125470
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dispersity of drugs with special reference to the dispersion ointments. 6. Changes in dispersity during the processing of drug powders into suspension ointments].
    Kögel J; Horsch W
    Pharmazie; 1976 Apr; 31(4):232-5. PubMed ID: 935225
    [No Abstract]   [Full Text] [Related]  

  • 19. Challenge test. Suggested method for pharmaceutical preparations.
    Apostolo E; Gerosa D; Zaia P
    Boll Chim Farm; 1972 Oct; 111(10):637-40. PubMed ID: 4644475
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of parenteral and sterile ophthalmic suspensions--the R & D approach.
    Portnoff JB; Cohen EM; Henley MW
    Bull Parenter Drug Assoc; 1977; 31(3):136-43. PubMed ID: 880416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.